Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02153008 · ClinicalTrials.gov registry record

Strep A FIA Field Study, Sofia

A clinical trial, sponsored by Quidel Corporation.

Completed
Registry status
1,708
Enrollment target

NCT02153008: Completed study, sponsored by Quidel Corporation.

NCT02153008 is a clinical trial that has completed, run by Quidel Corporation. The registered enrollment target is 1,708 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02153008 has completed, sponsored by Quidel Corporation.

COMPLETED
Registry status
1,708 participants
Enrollment target

Study Summary

To demonstrate the clinical performance of the Strep A FIA and Sofia, using throat swabs collected from symptomatic subjects.

Primary Outcome

A throat swab specimen will be obtained and tested for the presence of Group A Streptococcus via the Sofia Analyzer

Trial Details

FieldValue
Enrollment Target 1,708 participants
Start Date 2014-04
Est. Completion 2016-07-01
Quidel Corporation

9 total trials

What the finished NCT02153008 record still lists

NCT02153008 is an observational study that tracks outcomes without assigning an intervention. Its 1,708 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02153008 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02153008 about?

NCT02153008 is a clinical study titled "Strep A FIA Field Study, Sofia". To demonstrate the clinical performance of the Strep A FIA and Sofia, using throat swabs collected from symptomatic subjects.

What is the current status of trial NCT02153008?

This trial is currently completed. The enrollment target is 1,708 participants. The study started on 2014-04. Estimated completion is 2016-07-01.

Who is sponsoring clinical trial NCT02153008?

This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05303636 · 1,710 participants · Phase 4

    LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

  • NCT07304531 · 1,705 participants

    First To Know Pregnancy Test - Clinical Evaluation Protocol

  • NCT04291612 · 1,715 participants

    Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  • NCT04321200 · 1,700 participants

    PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02153008, the US trial registry maintained by the National Library of Medicine. NCT02153008 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.